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Introduction
“Lysosome” is a term originally coined by Christian de Duve in 
1955 (de Duve, 2005) to describe a newly discovered organelle 
that housed a pool of soluble hydrolases capable of degrading 
proteins, nucleic acids, carbohydrates, lipids, and cellular de-
bris. Because of these easily detectable activities, the lysosome 
quickly earned its reputation as the cell’s “trash can” or “recy-
cle bin.” There are multiple routes via which lysosomes receive 
their substrates. In general, extracellular material destined for 
degradation is delivered to the lysosome via endocytosis (Luzio 
et al., 2009), whereas intracellular waste is disposed of by the 
lysosome via a self-catabolic process known as autophagy (Rab-
inowitz and White, 2010; Singh and Cuervo, 2011). These cata-
bolic events occur in the highly acidic lumen (pH of ∼4.5–5.0) 
of the lysosome, which is segregated by a single lipid bilayer 
from the cytoplasm. To maintain the steady acidic environment 
required for its internal hydrolytic activities, the lysosome con-
stantly pumps in protons (H+ ions) across its limiting membrane 
by means of the vacuolar H+-ATPase (v-ATPase). This proton 
gradient also provides the driving force for the proton-coupled 
transport of metabolites, ions, and soluble substrates into and 
out of the lysosomal lumen (Forgac, 2007) and is necessary for 
proper targeting of newly synthesized lysosomal enzymes from 
the Golgi to the lysosome. Dissipation of the transmembrane 
proton gradient results in inefficient cargo sorting, altered mem-
brane traffic, impaired degradation of cellular waste, and even-
tually metabolic derangement (Saftig and Klumperman, 2009). 
In addition to its established role in cellular clearance, the ly-
sosome engages in various biological processes including se-
cretion, plasma membrane repair, immune response, cholesterol 
transport, and metal ion homeostasis, along with recently dis-
covered roles in nutrient sensing and gene regulation (Fig. 1).
Multiple lines of evidence have highlighted a close link 
between lysosomal activities and metabolic regulation at the 
systemic level. For example, regulation of lysosomal biogenesis 
and function appears critical for the execution of lipid catabolic 
programs in the liver (Settembre et al., 2013b). Moreover, inac-
tivating mutations in genes encoding for lysosomal hydrolases 
and transporters results in a spectrum of metabolic diseases 
known as lysosomal storage disorders (Futerman and van Meer, 
2004; Platt et al., 2012; Parenti et al., 2015). Timely activation of 
autophagy in neonatal tissues is also necessary for the survival 
of organisms, as genetic manipulation of several genes involved 
in autophagy and lysosomal signaling leads to embryonic le-
thality in mice (Kuma et al., 2004; Komatsu et al., 2005; Efeyan 
et al., 2013). Yet, we still lack a complete knowledge of the 
structural and functional organization of the lysosome and the 
mechanisms that enable its communication with other cellular 
compartments. Moreover, we are only beginning to appreciate 
how lysosomal composition and function evolve dynamically 
both within a cell and across different organs and tissues, as 
organisms transition through different metabolic states. In this 
review, we summarize recent advances in our current under-
standing of the molecular mechanisms of lysosomal adaptation, 
and we discuss how the lysosome may be a key mediator of 
physiological responses to changing metabolic conditions.
The lysosome as a metabolic signaling center
To cope with ever-changing external conditions, cells have 
evolved sophisticated signaling pathways that sense avail-
able nutrient and energy inputs and couple them with spe-
cific metabolic outputs. Many of these pathways, such as 
insulin–phosphoinositide 3-kinase (PI3K), are organized in a 
Lysosomes are membrane-bound organelles found in 
every eukaryotic cell. They are widely known as terminal 
catabolic stations that rid cells of waste products and 
scavenge metabolic building blocks that sustain essential 
biosynthetic reactions during starvation. In recent years, 
this classical view has been dramatically expanded by the 
discovery of new roles of the lysosome in nutrient sensing, 
transcriptional regulation, and metabolic homeostasis. 
These discoveries have elevated the lysosome to a deci-
sion-making center involved in the control of cellular 
growth and survival. Here we review these recently dis-
covered properties of the lysosome, with a focus on how 
lysosomal signaling pathways respond to external and 
internal cues and how they ultimately enable metabolic 
homeostasis and cellular adaptation.
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“top-down” manner, as they involve the engagement of a 
growth factor ligand to its receptor on the cell surface, fol-
lowed by signal propagation inside the cell (Taniguchi et al., 
2006). Growth factor–derived signals trigger changes in the 
rate of biochemical reactions occurring in the cytoplasm and 
inside specialized compartments such as mitochondria, per-
oxisomes, and lysosomes, ultimately steering the cell toward 
an anabolic or catabolic path (Ward and Thompson, 2012). 
In contrast to pathways originating at the cell surface, little is 
known as to whether intracellular organelles are capable of ini-
tiating signaling events on their own, particularly in response 
to changing metabolic conditions, and to communicate their 
internal status to each other.
Because it represents the endpoint of multiple cata-
bolic pathways, the lysosome also serves as a nutrient res-
ervoir that buffers variations in nutrient availability and can 
actively modify the composition and abundance of the cy-
toplasmic metabolite pool. The key role of the lysosome in 
maintaining metabolic homeostasis emerged early on from 
studies in yeast, a model organism that offers two key ad-
vantages, namely the ability to easily isolate intact, func-
tional vacuoles (the equivalent structure of the mammalian 
lysosome), coupled with powerful genetic approaches. It 
was found that the yeast vacuolar membrane hosts an array 
of nutrient transporters and permeases that allow bidirec-
tional transport of solutes (Ohsumi and Anraku, 1981; Li 
and Kane, 2009). Metabolite transport across the vacuolar 
membrane is highly regulated and leads to the buildup of 
major stores of cationic amino acids, polyphosphates, ions, 
and other building blocks that can be subsequently released 
on demand. Because of the high conservation of lysosomal 
enzymes and permeases between yeast and mammals, it is 
likely that the mammalian lysosome has a similar ability for 
selective retention and release of metabolic building blocks. 
Through these processes, the lysosome not only can affect 
the rate of metabolic reactions occurring elsewhere in the 
cell, but also can communicate the overall metabolic state 
of the cell to nutrient-sensing modules. One such module is 
an ancient protein kinase known as the mechanistic target of 
rapamycin complex 1 (mTORC1), which has recently been 
shown to be functionally and physically associated with the 
lysosome from yeast to humans (Sancak et al., 2008, 2010; 
Sturgill et al., 2008; Binda et al., 2009; Zoncu et al., 2011a). 
Elucidating the connection between mTORC1 and the lyso-
some has brought about a paradigm shift in the way we un-
derstand lysosome biology.
Functional organization of the mTORC1 
pathway at the lysosome
The mTORC1 pathway was identified because its core compo-
nent, the large (230-kD) serine/threonine kinase mTOR, is the 
target of the growth-inhibiting macrolide rapamycin (Heitman 
et al., 1991; Brown et al., 1994; Sabatini et al., 1994). A vast 
body of research has shown that the main role of mTORC1 is to 
integrate environmental and intracellular cues, such as growth 
factors, nutrient availability, energy status, and stresses, to ac-
tively drive cell growth and proliferation (Laplante and Saba-
tini, 2012; Dibble and Manning, 2013). Under favorable growth 
conditions, mTORC1 and its downstream effectors promote 
anabolic programs including mRNA translation, ribosome bio-
genesis, and lipid synthesis. Conversely, under stressful condi-
tions, mTORC1 activities are largely inhibited to give way to 
catabolic programs such as autophagy, which allow mobiliza-
tion of nutrient and energy stores.
mTORC1 is a multi-subunit protein kinase complex that, 
in addition to the core kinase mTOR, includes the large adaptor 
subunit RAP TOR (KOG1 in yeast), which is thought to mediate 
substrate binding (Hara et al., 2002; Kim et al., 2002) and subcel-
lular localization of the complex (Sancak et al., 2008, 2010); two 
components, PRAS40 (Sancak et al., 2007) and DEP TOR (Peter-
son et al., 2009), that inhibit intrinsic mTOR kinase activity, and 
G protein β subunit–like mLST8 (Kim et al., 2003), whose func-
tion remains obscure (Guertin et al., 2006). Multiple metabolic 
inputs including amino acids, glucose, and growth factors control 
mTORC1 via distinct mechanisms (Jewell and Guan, 2013; Shi-
mobayashi and Hall, 2014; Efeyan et al., 2015), albeit to varying 
degrees, as none of them alone can fully stimulate mTORC1 on 
its own. In nutrient-starved mammalian cells, mTORC1 is dif-
fuse throughout the cytoplasm. Readdition of nutrients, particu-
larly amino acids, causes the rapid translocation of mTORC1 to 
the surface of the lysosome. At the lysosome, the kinase activity 
of mTORC1 is turned on in a growth factor–dependent manner 
(Sancak et al., 2008, 2010; Zoncu et al., 2011a). Thus, the pre-
vailing model is that of coincidence detection: for mTORC1 to 
become fully activated, both local nutrients (particularly amino 
acids) and long-range nutritional signals carried by insulin must 
be present (Sancak et al., 2008, 2010; Zoncu et al., 2011a).
These discoveries established a key role for the lysosome 
in nutrient sensing, as no other organelle is able to support 
mTORC1 recruitment and activation. The lysosome membrane 
harbors specialized molecular machinery that recruits and ac-
tivates mTORC1 in response to amino acids (Sancak et al., 
2010), and several components of this machinery are conserved 
Figure 1. Expanding roles of the lysosome in key 
cellular processes. Lysosomes play pivotal roles in 
cellular clearance by engaging with either autopha-
gosomes or late endosomes to facilitate the degrada-
tion and recycling of internal and external substrates. 
Upon plasma membrane injury, lysosomes can repair 
the damaged site by fusing locally with the plasma 
membrane. Specialized cell types such as cytotoxic T 
cells and natural killer cells are capable of secreting 
cytolytic proteins from lysosomes to destroy infected 
or tumorigenic cells. Furthermore, lysosomes act as 
a storage site where amino acids, phosphate, ions, 
and intermediate metabolites can be selectively trans-
ported and retained. Emerging evidence indicates that 
the lysosome functions as a signaling hub for nutrient- 
sensing pathways converging on the mTORC1 kinase 
and can elicit a transcriptional response to meet cellu-
lar demands for nutrients and energy.
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all the way to yeast (Chantranupong et al., 2015). However, in 
yeast, mTORC1 remains stably associated with the vacuolar 
membrane even when amino acids are low (Binda et al., 2009; 
Péli-Gulli et al., 2015). This important difference may reflect 
the more complex cellular organization of higher eukaryotes. 
For instance, budding yeast lacks a canonical insulin-PI3K 
pathway, thus negating the need for a coincidence detection 
mechanism (Efeyan et al., 2012).
mTORC1 activation by the PI3K-RHEB axis
The small GTPase Ras homologue enriched in brain (RHEB) 
contains a C-terminal farnesylation motif that mediates its as-
sociation with the endomembrane system, including, but not 
limited to, the lysosome, where it serves as a potent activator 
of mTORC1 kinase activity (Inoki et al., 2003b; Saucedo et al., 
2003; Stocker et al., 2003; Zhang et al., 2003). Rheb is indis-
pensable for mTORC1 activation by virtually all stimuli. How-
ever, exactly how Rheb turns on mTORC1 is yet to be resolved.
Because of its intrinsically slow GTP hydrolysis activity, 
Rheb is preferentially in its GTP-bound form at all times and 
therefore has to be kept under stringent regulation by its inhib-
itor, the trimeric tuberous sclerosis complex (TSC, composed 
of TSC1, TSC2, and TBC1D7 subunits; Inoki et al., 2003b; 
Zhang et al., 2003; Dibble et al., 2012). Specifically, the TSC2 
component displays GTPase-activating protein (GAP) activity 
that converts Rheb into its GDP-bound state and therefore neg-
atively regulates mTORC1 (Inoki et al., 2003b; Zhang et al., 
2003). Upon stimulation by growth factors such as insulin, the 
serine/threonine kinase AKT is activated in a PI3K-dependent 
manner and phosphorylates TSC2 (Dan et al., 2002; Inoki et 
al., 2002). AKT-dependent TSC2 phosphorylation induces dis-
sociation of TSC from the lysosome, where TSC was shown to 
reside in growth factor–deprived conditions, and thus blocks its 
inhibitory effects toward Rheb (Demetriades et al., 2014, 2016; 
Menon et al., 2014). In addition to growth factors, the activity 
of TSC is regulated by low energy (Inoki et al., 2003a), hypoxia 
(Brugarolas et al., 2004; Reiling and Hafen, 2004), and geno-
toxic stress (Budanov and Karin, 2008), which collectively re-
strict mTORC1-mediated cell growth. Thus, TSC is one, but not 
the only, integration node for multiple signals that ultimately 
affect the kinase output of mTORC1.
mTORC1 recruitment by Rag GTPases
To be activated, mTORC1 needs to translocate to the lysosome 
membrane where Rheb resides. It turns out that amino acids 
directly regulate the lysosomal recruitment of mTORC1 by 
modulating the guanine nucleotide state of the Rag GTPases 
(Kim et al., 2008; Sancak et al., 2008; Binda et al., 2009). The 
Rags assemble as obligate heterodimers composed of RagA or 
RagB (which are similar to each other and homologous to Gtr1 
in Saccharomyces cerevisiae) associated with RagC or RagD 
(homologous to yeast Gtr2) and are tethered to the lysosomal 
membrane by the pentameric Ragulator complex (known as the 
Ego complex in yeast), composed of the LAM TOR1-5 proteins 
(Binda et al., 2009; Nada et al., 2009; Sancak et al., 2010; Bar-
Peled et al., 2012; Powis et al., 2015). Under amino acid suffi-
ciency, the Rag GTPase complex becomes active by adopting 
a nucleotide state in which Rag-A/B is GTP-loaded and Rag-
C/D is GDP-loaded and facilitates the lysosomal attachment 
of mTORC1 by directly interacting with Raptor (Sancak et al., 
2010; Bar-Peled et al., 2012). As such, the cycling of Rag het-
erodimers between their active and inactive states in an amino 
acid–sensitive fashion is tightly regulated by their correspond-
ing GAPs and guanine nucleotide exchange factors (GEFs), 
as well as posttranslational modifications (Table  1). Specif-
ically, Ragulator acts as a GEF that promotes the loading of 
Rag-A/B with GTP and thus activates mTORC1 (Binda et al., 
2009; Bar-Peled et al., 2012). Two GAP complexes stimulate 
GTP hydrolysis. Under low amino acids, GAT OR1 (SEA CIT 
in yeast) promotes GTP hydrolysis by Rag-A/B, thus switching 
off the pathway (Dokudovskaya and Rout, 2011; Bar-Peled et 
al., 2013; Panchaud et al., 2013). In contrast, in the presence of 
amino acids, Folliculin/FNIP (yeast Lst4/Lst7) causes Rag-C/D 
to become GDP loaded, enabling the Rags to bind to mTORC1 
and recruit it to the lysosome (Tsun et al., 2013; Péli-Gulli et 
al., 2015). The placement of the Rag GTPases downstream of 
amino acids in the mTORC1 pathway has provided important 
clues toward the long-sought-after questions of how and where 
amino acids are sensed in the cell.
Amino acid sensing inside the lysosome
It was initially proposed that plasma membrane amino acid 
transporters be potential candidates for amino acid sensors be-
cause of their roles in controlling the influx of amino acids into 
the cell (Christie et al., 2002; Beugnet et al., 2003). However, 
treatment with cycloheximide, a protein synthesis blocker that 
increases the concentration of free amino acids in the cyto-
plasm, is sufficient to restore mTORC1 signaling in cells that 
have been deprived of extracellular amino acids. This evidence 
strongly suggests that amino acid sensing should originate in-
tracellularly (Price et al., 1989; Christie et al., 2002; Beugnet 
et al., 2003; Sancak et al., 2008). The presence of the molec-
ular machinery for amino acid–regulated mTORC1 activation 
at the lysosome membrane also implies that amino acids may 
be sensed somewhere in close proximity to the lysosome. Sim-
ilar to the vacuole in yeast, the lysosome appears to accumulate 
significant amounts of amino acids within its lumen (Harms et 
al., 1981; Zoncu et al., 2011b). Using a cell-free assay, it was 
shown that binding of mTORC1 to the Rag GTPases is stimu-
lated by entry of amino acids into the lysosomal lumen. Con-
versely, both in vitro and in cells, preventing lysosomal amino 
acid accumulation blocked mTORC1 binding to the lysosomal 
surface (Zoncu et al., 2011b; Jung et al., 2015; Rebsamen et al., 
2015; Wang et al., 2015a). These results are compatible with a 
model for amino acid sensing by mTORC1 in which accumu-
lation of amino acids in the lysosomal lumen is relayed to the 
Rag GTPases at the lysosomal surface in an inside-out manner.
An RNAi screening in Drosophila melanogaster S2 cells 
revealed that the v-ATPase is a component of the lysosomal 
amino acid sensing machinery along with the Rag GTPases and 
Ragulator (Zoncu et al., 2011b). The v-ATPase forms a super-
complex with Ragulator and the Rag GTPases, and its catalytic 
activity is essential for mTORC1 recruitment in response to 
amino acids (Zoncu et al., 2011b; Bar-Peled et al., 2012; De-
chant et al., 2014; Jewell et al., 2015). Although the precise 
mechanism of action of the v-ATPase in amino acid sensing 
remains to be elucidated, an attractive possibility is that amino 
acids may regulate the assembly and/or activity of the complex 
(Stransky and Forgac, 2015).
Among the 20 amino acids, leucine and arginine are key 
activators of mTORC1 (Hara et al., 1998; Wang et al., 1998) up-
stream of the Rag GTPases (Sancak et al., 2008). Of note, argi-
nine, an amino acid crucial for mammalian embryogenesis and 
early development, is highly concentrated in rat liver lysosomes 
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and yeast vacuoles (Wiemken and Dürr, 1974; Boller et al., 
1975; Dürr et al., 1979; Harms et al., 1981; Kitamoto et al., 
1988). SLC38A9, a putative sodium-coupled amino acid trans-
porter in the lysosome membrane, recently has been proposed 
as a sensor that signals arginine sufficiency to mTORC1 (Jung 
et al., 2015; Rebsamen et al., 2015; Wang et al., 2015a). Bio-
chemical analysis demonstrated that SLC38A9 acts upstream 
of the Rag GTPases and Ragulator and in parallel with the 
v-ATPase. In amino acid transport assays using reconstituted 
liposomes, SLC38A9 transports arginine, but not leucine, into 
the lysosome, albeit with relatively low affinity compared with 
other amino acid transporters. Overexpression of the N-termi-
nal cytoplasmic domain of SLC38A9 is sufficient to render the 
mTORC1 signaling resistant to amino acid depletion (Jung et 
al., 2015; Rebsamen et al., 2015; Wang et al., 2015a), suggest-
ing that this domain acts downstream of the amino acid trans-
port function. Thus, SLC38A9 may function as a “transceptor” 
that, by transporting arginine across the lysosomal membrane, 
relays an activating signal toward mTORC1. How arginine 
binding mechanistically regulates SLC38A9 remains to be de-
termined. Also, the functional relationship between SLC38A9 
and the v-ATPase is unclear. Interestingly, deleting SLC38A9 
reduces mTORC1 substrate phosphorylation but not its localiza-
tion to the lysosome (Jung et al., 2015; Rebsamen et al., 2015), 
whereas v-ATPase inhibition affects both (Zoncu et al., 2011b).
Other lysosomal amino acid transporters implicated in 
mTORC1 activation include a histidine transporter, SLC15A4 
(Kobayashi et al., 2014), as well as proton-assisted amino acid 
transporter 1 (PAT1)/SLC36A1 (Ögmundsdóttir et al., 2012), 
which has transport specificity toward small neutral amino 
acids. Whether and how SLC15A4 and PAT1 function upstream 
of the Rag GTPases remains to be determined.
Glutamine, the most abundant free amino acid in the 
human body, provides a carbon and nitrogen source for cell 
growth. On one hand, several studies indicated that glutamine 
and glutamine-derived metabolites appear to function upstream 
of the Rag GTPase orthologues, Gtr1 and 2 (Binda et al., 2009; 
Durán et al., 2012; Péli-Gulli et al., 2015). On the other hand, 
it was shown that glutamine can stimulate lysosomal transloca-
tion and activation of mTORC1 via a Rag GTPase-independent 
mechanism, as revealed in recent studies using yeast (Stracka et 
al., 2014) and Rag-A/B deleted cells (Jewell et al., 2015). Inter-
estingly, stimulation of mTORC1 by glutamine does not require 
Ragulator, but still relies on the lysosome and the activity of the 
v-ATPase. Moreover, ADP-ribosylation factor 1 (ARF1), a Gol-
gi-localized small GTPase, is required in an undefined pathway 
that links glutamine to mTORC1 localization at the lysosome 
(Jewell et al., 2015). Further investigations are necessary to de-
termine the location of the mTORC1-activating glutamine pool 
and to establish the glutamine sensor upstream of Arf1.
Amino acid sensing in the cytoplasm
Recent evidence indicates that cytosolic free amino acids also 
play a major role in mTORC1 activation. Sestrin-2, a member 
of the Sestrin family of stress-responsive proteins (Budanov and 
Karin, 2008), has been shown to be a specific sensor for leucine 
in mammalian cells (Saxton et al., 2016; Wolfson et al., 2016). 
Under leucine deprivation, Sestrin-2 inhibits mTORC1 signal-
ing by sequestering GAT OR2, which represses the GAP activity 
of GAT OR1 toward Rag-A/B. The crystal structure of Sestrin-2 
revealed that Sestrin-2 contains a leucine-binding pocket local-
ized to its C-terminal domain (Kim et al., 2015; Saxton et al., 
2016). Binding of leucine disrupts the Sestrin2–GAT OR2 inter-
action and thus allows GAT OR2 to promote mTORC1 activa-
tion via inhibition of GAT OR1 activity. Mutations of Sestrin-2 
that abolish binding to GAT OR2 lead to constitutive activation 
of mTORC1 in the absence of leucine, whereas those that di-
minish binding to leucine suppress mTORC1 activation regard-
less of leucine availability.
In contrast, a newly characterized vertebrate-specific pro-
tein named CAS TOR1 (previously named GAT SL3) functions 
as a cytoplasmic arginine sensor for mTORC1 by binding to 
physiological concentrations of arginine through the con-
served ACT domains (Chantranupong et al., 2016). The CAS 
Table 1. Regulators of the RAG GTPases involved in mediating amino acid signaling to mTORC1
Yeast orthologues Mammalian 
orthologues






Ragulator LAM TOR1 (p18), LAM TOR2 
(p14), LAM TOR3 (MP1), 
LAM TOR4 (C7orf59), 
LAM TOR5 (HBX IP)
GEF for Rag-A/B; tethers the 
Rags to the lysosome
Up Binda et al., 2009; Nada et al., 
2009; Sancak et al., 2010; 
Bar-Peled et al., 2012; Powis et 
al., 2015
SEA CIT (Sea1, Npr2, 
Npr3)
GAT OR1 DEP DC5, Nprl2, Nprl3 GAP for Rag-A/B Down Dokudovskaya and Rout, 2011; 
Bar-Peled et al., 2013; Panchaud 
et al., 2013
SEA CAT (Sea4, 
Seh1, Sea2, 
Sea3, Sec13)
GAT OR2 Mios, Seh1L, WDR24, 
WDR59, Sec13
Inhibits GAT OR1 Up Dokudovskaya et al., 2011; 
Bar-Peled et al., 2013; Panchaud 
et al., 2013
Lst4/Lst7 FOL LIC ULIN FNIP1/2-FLCN GAP for Rag-C/D Up Petit et al., 2013; Tsun et al., 2013; 
Péli-Gulli et al., 2015
SH3BP4 SH3BP4 Inhibits Rag-A/B through direct 
binding
Down Kim et al., 2012
RNF152 RNF152 Ubiquitinates (K63) RagA, 
promotes interaction 
between RagA and GAT 
OR1
Down Deng et al., 2015
SKP2 SKP2 Ubiquitinates (K63) RagA, 
promotes interaction 
between RagA and GAT 
OR1
Down Jin et al., 2015
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TOR1-dependent mechanism of arginine sensing is highly anal-
ogous to leucine sensing by Sestrin-2. Under arginine depriva-
tion, homodimers of CAS TOR1, or heterodimers of CAS TOR1 
and CAS TOR2, bind tightly to GAT OR2. Refeeding of argi-
nine liberates GAT OR2 from this inhibitory interaction, thereby 
promoting mTORC1 activation. Additional work elucidating 
the structure and function of GAT OR2 is required to clarify 
whether the inhibitory actions of Sestrin-2 and CAS TOR1 to-
ward GAT OR2 operate through similar or distinct mechanisms. 
The presence of both cytoplasmic and lysosomal amino acid 
sensing systems raises intriguing questions about their relative 
importance and the mechanisms that coordinate their activi-
ties upstream of mTORC1.
Additional proteins have been proposed to play a role 
in relaying an amino acid signal to mTORC1, including the 
Ste20 family kinase MAP4K3 (Findlay et al., 2007; Bryk et 
al., 2010; Yan et al., 2010), leucyl-tRNA synthetase (Bonfils et 
al., 2012; Han et al., 2012), the scaffold protein SH3BP4 (Kim 
et al., 2012), and the autophagic adaptor p62/SQS TM1 (Duran 
et al., 2011). Further work is needed to determine the specific 
role of each protein and how their regulatory inputs are coordi-
nated upstream of mTORC1.
In summary, the aforementioned discoveries are illu-
minating the pivotal roles of the lysosome in regulating the 
switch between catabolic and anabolic metabolism and foster 
a unifying model of nutrient sensing by which all the signals 
from intracellular nutrients and exogenous growth factors are 
integrated at the lysosomal surface (Fig. 2). This model likely 
undergoes variations between species or even among different 
organs and tissues of multicellular organisms. Interestingly, 
S. cerevisiae lacks Sestrin and CAS TOR homologues, suggest-
ing that yeast mTORC1 may preferentially sense amino acids in 
the vacuole (the main cellular repository for these metabolites) 
or that it may be more concerned with nitrogen abundance than 
with the levels of any specific amino acid (Bahn et al., 2007).
Also, any proteins or small molecules able to interact 
with and regulate the mTORC1-activating supercomplex may 
provide additional regulatory mechanisms. Thus, it is con-
ceivable that additional nutrient inputs upstream of mTORC1 
wait to be discovered.
Transcriptional regulation of 
lysosomal function
For a long time, the lysosome was thought of as a metabolic 
“dead end,” a static compartment that, unlike mitochondria or 
peroxisomes, is not subjected to feedback regulation by the nu-
trient state of the cell. This view has been radically altered by 
the recent discovery of a vast and coordinated transcriptional 
program controlled by the transcription factor EB (TFEB), 
along with other members of the microphthalmia-transcription 
factor E (MiT/TFE) subfamily (Rehli et al., 1999; Sardiello et 
al., 2009; Settembre et al., 2011).
These basic helix-loop-helix (HLH) transcription factors 
up-regulate the expression of genes encoding for lysosomal and 
autophagic proteins by preferentially binding to a 10-bp GTC 
ACG TGAC motif found within their promoters and termed co-
ordinated lysosomal expression and regulation (CLE AR) ele-
ment (Sardiello et al., 2009; Palmieri et al., 2011; Settembre et 
al., 2011). The nutrient status of the cell, along with other envi-
ronmental cues, tightly controls the expression of the CLE AR 
network through the cytoplasmic-nuclear shuttling of TFEB. 
Under nutrient-rich conditions, TFEB is recruited to the lyso-
somes via its physical interaction with the Rag GTPases. At 
the lysosomal surface, mTORC1 phosphorylates TFEB on two 
critical residues, Ser142 and Ser211. Phosphorylated TFEB is 
then retained in the cytoplasm via binding to 14-3-3 proteins 
(Martina et al., 2012; Roczniak-Ferguson et al., 2012; Settem-
bre et al., 2012; Martina and Puertollano, 2013). Upon nutrient 
withdrawal or lysosomal stress, TFEB undergoes dephosphor-
ylation and rapidly translocates to the nucleus to activate the 
transcription of CLE AR genes, including lysosomal hydro-
lases, pumps, and permeases, along with autophagic regulatory 
proteins. Thus, the net effect of TFEB activation is an increase 
in autophagic flux matched by an expansion of the lysosomal 
compartment, thereby boosting the ability of the cell to adapt to 
nutrient-poor and stressful conditions.
Calcineurin, a calcium-dependent phosphatase, is re-
sponsible for TFEB dephosphorylation on Ser142 and Ser211 
and thus promotes TFEB entry into the nucleus (Medina et al., 
2015). Interestingly, it is thought that the lysosomal calcium pool 
controls calcineurin activation and TFEB dephosphorylation. 
Figure 2. The lysosome as a signaling hub 
for nutrient sensing. Under growth-promoting 
conditions, signals from amino acids, energy, 
oxygen, and growth factors are integrated up-
stream of the Rag and Rheb GTPases to facili-
tate the recruitment and activation of mTORC1. 
Loss of any of these inputs leads to shutdown of 
mTORC1 signaling by blocking its lysosomal 
recruitment, kinase activation, or both.
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Starvation triggers release of calcium from the lysosomal lumen 
via MCO LN1/TRP ML1, a multispan lysosomal ion trans-
porter, and inhibition of MCO LN1 by genetic inactivation and 
pharmacological approaches impaired TFEB nuclear transloca-
tion and autophagy induction (Medina et al., 2015; Wang et al., 
2015b). MITF and TFE3, which are also members of the MiT/
TFE family, can form homodimers or heterodimers with TFEB 
and are regulated by similar mechanisms (Roczniak-Ferguson 
et al., 2012; Martina and Puertollano, 2013). How starvation 
increases MCO LN1-mediated lysosomal Ca2+ release remains 
elusive. A recent study (Wang et al., 2015b) has suggested that 
nutrient-induced changes in the levels of phosphatidylinosi-
tol-(3,5)-bisphosphate, a known activator of TRP ML1, may be 
involved in this process.
Phosphoproteomic studies revealed that TFEB possesses 
multiple sites of phosphorylation (Dephoure et al., 2008; 
Peña-Llopis et al., 2011; Settembre et al., 2011; Ferron et al., 
2013), suggesting that mTORC1-independent signaling path-
ways could also modulate the nuclear translocation of TFEB. 
Consistently, the ERK2 kinase phosphorylates TFEB at serine 
142 in response to growth factor stimulation and restricts its 
nuclear localization (Settembre et al., 2011). MITF is also sub-
jected to phosphorylation by c-kit and WNT signaling on the 
sites that are conserved in TFEB and TFE3 (Wu et al., 2000; 
Ploper et al., 2015). All these findings indicate that the phosphor-
ylation-dependent regulation of TFEB represents a universal 
mechanism of lysosomal adaptation to combat cellular stresses.
TFEB regulation and function are evolutionarily con-
served from nematodes to humans, and at the organism level 
TFEB-driven transcriptional responses mediate important 
physiological processes such as lipid catabolism, longevity, 
and organismal survival. Experimental evidence indicates that 
TFEB expression is up-regulated in mice after food deprivation 
or energy expenditure (Settembre et al., 2013b; Medina et al., 
2015). Overexpression of TFEB in mouse liver attenuated di-
et-induced obesity by promoting lipid catabolism. In contrast, 
lipid degradation pathways were impaired in hepatocytes from 
liver-specific TFEB knockout mice (Settembre et al., 2013b). 
These liver-specific functions of TFEB result from its ability to 
activate a transcriptional program for lipid catabolism through 
direct up-regulation of peroxisome proliferator-activated re-
ceptor α (PPARα) and peroxisome proliferator-activated recep-
tor gamma coactivator 1α (PGC1α), which are key regulators 
of lipid breakdown in response to starvation. Thus, TFEB- 
mediated programs allow the organism to derive energy from 
the stored lipids, linking lysosomal function to the mainte-
nance of cellular energy balance (Rabinowitz and White, 2010; 
Singh and Cuervo, 2011).
A TFEB-mediated adaptive response could also contrib-
ute to the extended lifespan seen in the nematode Caenorhabdi-
tis elegans, in which the TFEB homologue, known as HLH-30, 
acts similarly to its human counterpart to promote lipid mobili-
zation and autophagy in fasting worms (Kaeberlein et al., 2006; 
Lapierre et al., 2013; O’Rourke and Ruvkun, 2013), whereas 
loss of HLH-30 diminishes the starvation-induced lifespan ex-
tension (Settembre et al., 2013b). Further investigation is re-
quired to determine whether modulating the expression and 
activity of TFEB would impact the lifespan of higher organ-
isms. Of note, the capability of TFEB to promote cellular clear-
ance could also be exploited to develop novel therapeutics for 
diseases associated with lysosomal and autophagic dysfunction 
such as lysosomal storage diseases (Settembre et al., 2013a; 
Spampanato et al., 2013; Lim et al., 2015) and common neuro-
degenerative diseases including Parkinson’s, Alzheimer’s, and 
Huntington’s diseases. It was observed that TFEB activation by 
Non-mTORC1–related signaling functions of the lysosome
In addition to regulating mTORC1, the lysosome plays an important role 
in other major signaling pathways by mediating either the breakdown of 
activated receptors for signal termination or the proteolytic activation of 
signaling ligands. Two notable examples are discussed here:
(1) In canonical receptor tyrosine kinase (RTK) pathways, binding of the 
epidermal growth factor (EGF) to its receptor EGFR/ErbB1 at the cell 
surface triggers receptor dimerization and cross-phosphorylation of the 
EGFR intracellular kinase domains; phosphorylated domains then recruit 
and activate effectors such as the small GTPase Ras and the lipid kinase 
PI3K. Activation of these effectors is essential for the propagation of the 
EGF-initiated signal to a set of protein kinases such as the MAPK/ERK 
kinases, which convert the initial ligand–receptor binding into a mito-
genic response (Avraham and Yarden, 2011; Tomas et al., 2014). The 
degradation of activated EGFR in the lysosome is a key step for termi-
nation of this highly mitogenic signal. Phosphorylated EGFR triggers its 
own ubiquitination by the E3 ligase Cbl; endocytic adaptors containing 
ubiquitin-interacting motif, such as epsin and Eps15, recognize ubiquiti-
nated EGFR and promote its internalization into endocytic vesicles (Tomas 
et al., 2014). Internalized EGFR is then trafficked via Rab5-positive early 
endosomes to Rab7-positive late endosomes and progressively removed 
from the endosomal-limiting membrane via ESC RT-mediated budding of 
intraluminal vesicles. Through further rounds of fusion, these EGFR-load-
ed late endosomes then convert into mature lysosomes, wherein cathep-
sin proteases and lipases degrade the EGFR-loaded intraluminal vesicles 
(Tomas et al., 2014). The key role of this lysosome-based degradative 
pathway in signal down-regulation is highlighted by the presence of in-
activating mutations of Cbl in various malignancies (Makishima et al., 
2009; Tan et al., 2010), resulting in constitutive EGFR signaling at the 
plasma membrane. Moreover, this mode of regulation is shared by other 
RTKs, including platelet-derived growth factor receptor and insulin-like 
growth factor receptor. Thus, in the context of RTK signaling, the lysosom-
al lumen functions primarily as an endpoint for signal down-regulation, 
thereby playing an important role in limiting the mitogenic effect of EGFR.
(2) The lysosome is also an important signaling station for innate immu-
nity. This is an ancient pathogen-defense system in which specialized 
pattern recognition receptors (PRRs) recognize and bind to molecular 
signatures known as pathogen-associated molecular patterns shared by 
several classes of pathogens. A prominent class of PRRs is the Toll-like 
receptor (TLR) family (O’Neill et al., 2013). TLRs consist of leucine-rich 
repeat motifs in an antigen-binding ectodomain, a single pass transmem-
brane portion, and an intracellular Toll–IL-1 receptor (TIR) domain. Upon 
binding of the ectodomain to microbial ligands such as viral or bacterial 
proteins and nucleic acids, the ectodomain undergoes a conformational 
change that leads to the recruitment of specific adaptor proteins to the 
TIR. This binding event initiates a signaling cascade that mounts several 
anti-pathogen responses, including secretion of inflammatory cytokines 
and anti-microbial peptides, as well as activation of dendritic cells. Of 
the 13 known TLRs, TLR 3, 7, 8, and 9 localize to the endolysosomal 
compartment, with their ectodomain protruding into the lumen and the 
TIR facing the cytoplasm. These TLRs specialize in recognizing nucleic 
acids, which are released from invading pathogens that were taken up 
in intracellular compartments. Localization of TLRs to endocytic compart-
ments is thought to prevent them from recognizing “self” nucleic acids 
and thus mounting an autoimmune response. Moreover, full activation 
of these TLRs requires proteolytic processing of their ectodomain by pro-
teases such as asparagine endopeptidases and cathepsins in the acid-
ic lumen of the lysosome (Lee and Barton, 2014). After ligand binding 
and activation, TLR3 and TLR9 recruit adaptor proteins, such as TRIF and 
MyD88, respectively, to their TIR, triggering parallel signaling cascades 
that culminate with the activation of transcription factors and the release 
of inflammatory cytokines and interferons. Thus, in the context of innate 
immunity, the lysosomal lumen provides an ideal environment in which 
TLRs become fully activated and where they bind to their respective li-
gands, whereas the cytoplasmic face provides a platform for the recruit-
ment of secondary effectors that propagate the pathogen-initiated signal 
all the way to the nucleus.
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overexpression or pharmacological stimulation can attenuate 
protein aggregation in cellular and mouse models of neurode-
generative disease, likely through increased autophagic clear-
ance of protein aggregates (Polito et al., 2014; Xiao et al., 2014, 
2015; Chauhan et al., 2015).
At the organismal level, elimination of the TFEB gene in 
mouse is embryonically lethal because of defects in placental 
vascularization (Steingrímsson et al., 1998). Prosurvival ef-
fects of autophagy elicited by TFEB may also induce meta-
bolic reprogramming that favors cancer growth, for example, 
by deliberately accumulating nutrients such as amino acids in 
lysosomes. One notable example is human pancreatic ductal ad-
enocarcinoma, which displays increased number of lysosomes 
and enlarged autophagosomes as a result of constitutive nuclear 
localization and activation of MiT/TFE transcription factors, 
which are decoupled from mTORC1 regulation (Perera et al., 
2015). Moreover, gene fusions involving TFE3 or TFEB have 
been identified in patients with sporadic renal cell carcinoma 
(Komai et al., 2009; Mosquera et al., 2011; Zhong et al., 2012). 
A feature common to all TFE3 and TFEB fusion proteins is the 
retention of the wild-type protein C-terminus that is required 
for DNA binding, dimerization, and nuclear localization. How 
the translocated TFE3 and TFEB genes contribute to renal car-
cinogenesis remains poorly understood. A detailed investiga-
tion of the transcriptional programs that become constitutively 
activated will shed light on this important question (Kauffman 
et al., 2014; Magers et al., 2015).
The MiT/TFE proteins are prominent members of a rap-
idly expanding group of transcription factors involved in auto-
phagy-lysosome gene regulation. Emerging evidence has also 
suggested a key role for forkhead box O (FOXO) transcription 
factor family in the regulation of autophagy (Webb and Brunet, 
2014). Insulin and growth factor signaling negatively regulate 
FOXO transcriptional activity through AKT/SGK1-dependent 
phosphorylation, leading to FOXO exclusion from the nucleus 
and inhibition of its transcriptional activity (Biggs et al., 1999; 
Brunet et al., 1999, 2001; Kops et al., 1999). During starvation, 
when insulin and growth factors are absent, FOXO translocates 
into the nucleus and activates the expression of genes involved 
in stress response, metabolism, and cellular quality control 
(Calnan and Brunet, 2008). It was shown that FOXO3 is re-
quired for fasting-induced autophagy in muscles (Mammucari 
et al., 2007; Zhao et al., 2007). Overexpression of FOXO3 is 
sufficient to induce autophagosome, as revealed by increased 
foci of LC3-GFP in C2C12-derived myotubes and primary 
mouse myofibers, whereas knockdown of FOXO3 leads to de-
creased autophagosome formation (Mammucari et al., 2007; 
Zhao et al., 2007). Chromatin immunoprecipitation analysis in 
mouse muscle cells demonstrated that FOXO3 directly binds to 
the promoters of key autophagy genes including LC3b, Gabar-
apl1, Atg12l, Bnip3, and Bnip3l (Mammucari et al., 2007; Zhao 
et al., 2007). Therefore, FOXO3 may synergize with TFEB to 
maintain muscle functionality during fasting.
Just as turning on autophagy and lysosomal biogenesis 
in response to nutrient scarcity is critical for cellular survival, 
turning off these processes is equally important, as it allows 
cells to readjust their metabolic requirements when nutrients 
are replete. ZKS CAN3, a zinc finger transcription factor con-
taining KRAB and SCAN domains previously identified as a 
“driver” of cell proliferation (Ma et al., 2007; Yang et al., 2008), 
has been proposed as a master transcriptional repressor of auto-
phagy (Chauhan et al., 2013). ZKS CAN3 directly represses the 
expression of a repertoire of genes involved in sequential steps 
of autophagic process ranging from lysosome biogenesis to traf-
ficking and autophagosome-lysosome fusion. Similar to TFEB, 
ZKS CAN3 activity is regulated by nuclear-cytoplasmic shut-
tling but in the opposite way. Nutrient deprivation or mTORC1 
inhibition triggers cytoplasmic localization of ZKS CAN3 and 
silences its activity, whereas nutrient-rich conditions promote 
nuclear translocation of ZKS CAN3, leading to suppression 
of the autophagic response (Chauhan et al., 2013). Hence, by 
switching on and off multiple components of the autophagy- 
lysosome system through reciprocal regulation of TFEB and 
ZKS CAN3, the lysosome exerts its adaptation to meet meta-
bolic demands according to nutrient levels.
Farnesoid X receptor (FXR), which is a bile acid–acti-
vated nuclear receptor involved in regulation of bile acid, lipid, 
and glucose homeostasis, has also been shown to negatively 
regulate autophagy in the liver through multiple mechanisms 
(Lee et al., 2014; Seok et al., 2014). In the fed state, FXR com-
petes with PPARα for a common binding site in the promoter 
regions of key autophagy genes, resulting in their repression 
(Lee et al., 2014). Interestingly, mTORC1 also attenuates 
PPARα activity by promoting nuclear translocation of nuclear 
receptor corepressor 1, which is a transcriptional repressor of 
PPARα (Sengupta et al., 2010). Furthermore, in fed mice, FXR 
blocks the transcriptional activity of cAMP-responsive element 
binding protein (CREB) by disrupting the functional interac-
tion between CREB and its coactivator CRTC2. Because CREB 
promotes the expression of TFEB and other autophagic regula-
tors, decreased assembly of CREB/CRTC2 complex suppresses 
catabolism (Seok et al., 2014). Conversely, under fasting con-
ditions, FXR becomes inactive, thus leading to de-repression of 
the transcriptional activity of TFEB, PPARα, and the CREB–
CRTC2 complex. Together, these studies establish a mechanis-
tic link between nutrient-sensing transcription factors/nuclear 
receptors and the regulation of autophagy and lysosomal func-
tion and delineate an integrated regulatory network for meta-
bolic adaptation of increasing complexity.
Concluding remarks
The discovery of the lysosome-centric signaling networks for 
nutrient sensing and metabolic adaptation described herein has 
projected this organelle into the pilot’s seat of cellular phys-
iology. Clearly, more studies are required to achieve a com-
prehensive understanding of how the lysosome’s many parts 
interact under various physiological and pathological condi-
tions. Increasing evidence also suggests that this organelle 
may constantly communicate with other cellular structures to 
carry out specific metabolic programs. For instance, a contact 
site between the yeast mitochondria and vacuole named vCLA 
MP (vacuole and mitochondria patch) provides an alternative 
route to phospholipid transfer to the conventional route via 
mitochondria–endoplasmic reticulum contacts, and thus par-
ticipates in mitochondria biogenesis (Elbaz-Alon et al., 2014; 
Hönscher et al., 2014).
From a cell biological standpoint, studying lysosomal 
organization and plasticity will answer longstanding questions 
regarding the functional diversity of lysosomes in different 
tissues and organs, which is mediated by tissue- and cell-type 
specific gene expression but is also likely influenced by local 
metabolic conditions and age. Deciphering the molecular basis 
that determines the differences in lysosomal composition and 
function will help us understand how the lysosome acquires 
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specialized functions to carry out specific metabolic tasks. A 
good example is provided by lysosome-related organelles known 
as melanosomes, which specialize in the synthesis and storage 
of melanin pigment (Raposo and Marks, 2002, 2007). The mo-
lecular composition of melanosomes changes through sequential 
and well-defined stages of maturation (Raposo and Marks, 2002, 
2007). Moreover, melanosomes function differently according to 
cell type. In retinal pigment epithelial cells, melanosomes help 
detoxify phagocytosed photoreceptor outer membranes, whereas 
in epidermal melanocytes, melanosomes contribute to generation 
of the pigmentation of skin and hair by supplying melanins to 
neighboring keratinocytes (Dell’Angelica, 2003). Importantly, 
loss of ability to synthesize pigments and disorganization of 
melanosomal structures are associated with development of ma-
lignant melanoma. Hence, functional characterization of the mo-
lecular components of melanosomes throughout different stages 
of maturation and across cell types will not only provide insights 
into how they deviate from conventional lysosomes, but also help 
unravel the pathogenesis of melanoma.
A further emerging aspect is the heterogeneity of lyso-
somes within a cell. Lysosomes appear to have different abili-
ties to internally acidify and, potentially, to generate metabolic 
signals (Korolchuk et al., 2011; Johnson et al., 2016). These in-
trinsic differences may stem from the positioning of lysosomes 
within cells, which is controlled by specialized protein com-
plexes at the lysosomal surface and by the activity of lysosomal 
ion channels (Pu et al., 2015; Li et al., 2016).
With rapid advances in genomic editing and proteomic 
technologies, comparative analyses of lysosomal composition 
and function will allow us to better appreciate the important 
contributions of this organelle to many aspects of cellular me-
tabolism, organismal physiology, and disease.
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